Cellebrite DI (CLBT) Share-based Compensation (2021 - 2025)

Cellebrite DI's Share-based Compensation history runs 5 years deep, the most recent figure standing at $12.0 million for Q4 2025.

• In Q4 2025, Share-based Compensation rose 29.43% year-over-year to $12.0 million; the TTM figure through Dec 2025 stood at $44.9 million (up 46.83% YoY), while the FY2025 annual figure was $44.9 million, up 46.83% from the prior year.
• Share-based Compensation was $12.0 million for Q4 2025 at Cellebrite DI, down from $15.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $15.3 million in Q3 2025 to a low of $1.4 million in Q3 2021.
• Historically, Share-based Compensation has averaged $5.9 million across 5 years, with a median of $4.9 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation surged 144.04% in 2022, then increased 27.6% in 2023.
• A 5-year view of Share-based Compensation shows it stood at $1.7 million in 2021, then jumped by 128.0% to $3.8 million in 2022, then jumped by 33.61% to $5.1 million in 2023, then soared by 83.18% to $9.3 million in 2024, then climbed by 29.43% to $12.0 million in 2025.
• The last three Share-based Compensation figures came in at $12.0 million (Q4 2025), $15.3 million (Q3 2025), and $8.8 million (Q2 2025), per Business Quant data.